4 posts tagged with DNA by zarq.
Displaying 1 through 4 of 4.

Related tags:
+ (43)
+ (36)
+ (16)
+ (12)
+ (12)
+ (11)
+ (9)
+ (7)
+ (7)
+ (6)
+ (6)
+ (5)
+ (4)
+ (4)
+ (4)
+ (4)
+ (4)
+ (4)
+ (4)
+ (4)


Users that often use this tag:
homunculus (7)
zarq (4)
costas (3)
stbalbach (3)
mcgraw (3)
caddis (2)
Fizz (2)
chuckdarwin (2)
orthogonality (2)
dhruva (2)
magullo (2)
lola (2)
netbros (2)
Steven Den Beste (2)
mathowie (2)
The Lazarus File. "In 1986, a young nurse named Sherri Rasmussen was murdered in Los Angeles. Police pinned down no suspects, and the case gradually went cold. It took 23 years—and revolutionary breakthroughs in forensic science­—before LAPD detectives could finally assemble the pieces of the puzzle. When they did, they found themselves facing one of the unlikeliest murder suspects in the city’s history." [more inside]
posted by zarq on May 14, 2011 - 60 comments

The Someone You're Not: "Our packed prisons are starting to disgorge hundreds of mostly African-American men who, over the last few decades, we wrongly convicted of violent crimes. This is what it's like to spend nearly thirty years in prison for something you didn't do. This is what it's like to spend nearly thirty years as someone you aren't. And for Ray Towler, this is what it's like to be free." Via. [more inside]
posted by zarq on Feb 25, 2011 - 18 comments

Invasive amniocentesis and chorionic villi sampling (CVS) tests are commonly used to determine the chromosomal, structural and genetic abnormalities in fetuses. But could they eventually become obsolete? A Chinese study has found that a complete copy of the fetal genome exists in the mother's blood, suggesting many prenatal diagnoses could potentially be performed noninvasively. [more inside]
posted by zarq on Dec 8, 2010 - 30 comments

Followup to this post: A US District Court has ruled that Myriad Genetic's patents on breast cancer genes BRCA1 and BRCA2, which allow them to hold exclusive rights to a widely used genetic test for inherited breast and ovarian cancer susceptibility, are invalid. Genomics Law Report analyzes the ruling in two posts. The decision is likely to be challenged in a legal appeal — but if upheld, it could have huge implications for the biotechnology industry. [more inside]
posted by zarq on Mar 31, 2010 - 51 comments

Page: 1